Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Paul T. Quinlan currently holds 31,034 shares of CymaBay Therapeutics, Inc. (CBAY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul T. Quinlan has been a net seller of CBAY stock. They have purchased $0 and sold $3.3M worth of shares.
Paul T. Quinlan's most recent insider trade was on Jun 15, 2026, when they sold 733 shares at $69.69 per share.
Paul T. Quinlan serves as Executive at CymaBay Therapeutics, Inc. (CBAY). They have executed 108 insider transactions totaling $3.3M over their tenure at the company.
Paul T. Quinlan holds the position of Executive at CymaBay Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Paul T. Quinlan has shown a selling trading pattern, with $0 in total purchases and $3.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Paul T. Quinlan was on Sep 15, 2023, when they sold $404.9K worth of CBAY shares. This transaction involved 24,000 shares at $16.87 per share.
Paul T. Quinlan currently owns 31,034 shares of CymaBay Therapeutics, Inc. (CBAY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Paul T. Quinlan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Paul T. Quinlan has 108 Form 4 filings on record as an insider at CymaBay Therapeutics, Inc..
Set alerts for Paul T. Quinlan and 40,000+ other insiders.